Vascular Biology in Clinical Practice TM Vol. 7, No. 2
• New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy
This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy
, is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine. Co-editors are Carl J. Pepine, MD, University of Florida College of Medicine, and James O'Keefe, MD, FACC, University of Missouri-Kansas City Medical School.
Advances in the identification and validation of risk factors for cardiovascular disease (CVD) have been substantial. In this monograph, recently published results from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and related studies are discussed in the context of hypertension and dyslipidemia. These trials assess the efficacy of agents targeting multiple mechanisms of CVD in patients with defined risk factors.
The contents of this monograph express the views of the individual
contributors and do not necessarily reflect the views or
recommendations of the University of Florida College of Medicine,
University of Missouri-Kansas City Medical School, or the publisher.
The reader is advised to consult the full prescribing information for all
medications prior to use.
Supported by an educational grant from Pfizer Inc.
© 2006 MEDCONSM All rights reserved.